Power priors with entropy balancing weights in data augmentation of partially controlled randomized trials

In pediatric or orphan diseases, there are many instances where it is unfeasible to conduct randomized and controlled clinical trials. This is due in part to the difficulty of enrolling a sufficient number of patients over a reasonable time period to meet adequate statistical power to demonstrate th...

Full description

Saved in:
Bibliographic Details
Published inJournal of biopharmaceutical statistics Vol. 32; no. 1; pp. 4 - 20
Main Authors Yu, Guanglei, Bian, Yuanyuan, Gamalo, Margaret
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 02.01.2022
Taylor & Francis Ltd
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In pediatric or orphan diseases, there are many instances where it is unfeasible to conduct randomized and controlled clinical trials. This is due in part to the difficulty of enrolling a sufficient number of patients over a reasonable time period to meet adequate statistical power to demonstrate the treatment efficacy. One solution to reduce the sample size or expedite the trial timeline is to complement the current trial with real-world data. To this end, several propensity score-based methods have been developed to create defined groups of patients that are controlled for confounding based on a set of measured covariates at baseline. However, balance checking on the measured covariates and tweaks to the propensity score models is usually inevitable to achieve the joint balance across all covariates. To mitigate this iterative procedure, we utilize the entropy balancing weighting technique which focuses on balancing the covariates of subjects between the experimental and control groups directly and augments the current trial with the external control data via a power prior. The finite-sample properties of the proposed method are assessed via simulations in the context of asymmetrically randomized controlled trials where only a small portion of patients are randomized to the control group. Other methods such as covariate-balancing propensity score (CBPS) and propensity score matching (PSM) and weighting (PSW) are also compared to provide context on the operating characteristics of the proposed method.
AbstractList In pediatric or orphan diseases, there are many instances where it is unfeasible to conduct randomized and controlled clinical trials. This is due in part to the difficulty of enrolling a sufficient number of patients over a reasonable time period to meet adequate statistical power to demonstrate the treatment efficacy. One solution to reduce the sample size or expedite the trial timeline is to complement the current trial with real-world data. To this end, several propensity score-based methods have been developed to create defined groups of patients that are controlled for confounding based on a set of measured covariates at baseline. However, balance checking on the measured covariates and tweaks to the propensity score models is usually inevitable to achieve the joint balance across all covariates. To mitigate this iterative procedure, we utilize the entropy balancing weighting technique which focuses on balancing the covariates of subjects between the experimental and control groups directly and augments the current trial with the external control data via a power prior. The finite-sample properties of the proposed method are assessed via simulations in the context of asymmetrically randomized controlled trials where only a small portion of patients are randomized to the control group. Other methods such as covariate-balancing propensity score (CBPS) and propensity score matching (PSM) and weighting (PSW) are also compared to provide context on the operating characteristics of the proposed method.
Author Yu, Guanglei
Bian, Yuanyuan
Gamalo, Margaret
Author_xml – sequence: 1
  givenname: Guanglei
  orcidid: 0000-0003-0954-3397
  surname: Yu
  fullname: Yu, Guanglei
  email: yu_guanglei@lilly.com
  organization: Eli Lilly & Co
– sequence: 2
  givenname: Yuanyuan
  orcidid: 0000-0003-4736-2597
  surname: Bian
  fullname: Bian, Yuanyuan
  organization: Eli Lilly & Co
– sequence: 3
  givenname: Margaret
  orcidid: 0000-0003-2428-3298
  surname: Gamalo
  fullname: Gamalo, Margaret
  organization: Pfizer
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35072583$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v3CAQhlGVKF_NT2iF1EsuTgYMxr6lipK2UqT20J4RNrBhZcMGsFabX1-c3fSQQy_MSPPMMO-85-jIB28Q-kTgmkALNwQ4qxk01xQoeX0obT6gM8IpVFwQclTywlQLdIrOU1oDEC5adoJOaw6C8rY-Q-tfYWsi3kQXYsJbl5-w8TmGzQ73alR-cH6Ft8atnnLCzmOtssJqXk2FUtkFj4PFGxWzU-O4w0NYmsfRaByV12FyLyXNsVTTR3RsSzCXh3iB_jzc_777Xj3-_Pbj7utjNdQdyxVpaqr6hlCm26bpB2GYFZS02ig1dH1HiiprhQYNwKEfulKwVitL-q7IausLdLWfu4nheTYpy8mlwYxFjQlzkrShlLWEMVHQL-_QdZijL9vJGlrBiaCwUHxPDTGkFI2V5VyTijtJQC5myDcz5OKDPJhR-j4fps_9ZPS_rrfrF-B2DzhvQ5zUNsRRy6x2Y4g2Lscve_z_j79D3pwE
CitedBy_id crossref_primary_10_1080_10543406_2022_2036992
crossref_primary_10_1080_10543406_2022_2105346
crossref_primary_10_1080_10543406_2024_2330212
crossref_primary_10_3390_app13021227
Cites_doi 10.1002/pst.2172
10.1111/1468-0262.00442
10.1002/pst.1879
10.1111/j.1467-985X.2007.00527.x
10.1214/ss/1009212673
10.1111/rssb.12027
10.1080/10543406.2020.1730877
10.1038/bcj.2016.84
10.1093/pan/mpr025
ContentType Journal Article
Copyright 2022 Taylor & Francis Group, LLC 2022
2022 Taylor & Francis Group, LLC
Copyright_xml – notice: 2022 Taylor & Francis Group, LLC 2022
– notice: 2022 Taylor & Francis Group, LLC
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1080/10543406.2021.2021226
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Statistics
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-5711
EndPage 20
ExternalDocumentID 10_1080_10543406_2021_2021226
35072583
2021226
Genre Research Article
Journal Article
GroupedDBID ---
.7F
.QJ
0BK
0R~
29K
30N
36B
4.4
53G
5GY
5VS
8VB
AAAVI
AAENE
AAJMT
AALDU
AAMIU
AAPUL
AAQRR
ABBKH
ABCCY
ABDBF
ABFIM
ABHAV
ABJVF
ABLIJ
ABPEM
ABPTK
ABQHQ
ABTAI
ABXUL
ACGEJ
ACGFS
ACTIO
ADCVX
ADGTB
ADXPE
AEGYZ
AEISY
AEMOZ
AENEX
AEOZL
AEPSL
AEYOC
AFKVX
AFOLD
AFWLO
AGDLA
AGMYJ
AHDLD
AIJEM
AIRXU
AJWEG
AKBVH
AKOOK
AKVCP
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AQRUH
AVBZW
AWYRJ
BLEHA
CCCUG
CE4
CS3
D-I
DGEBU
DKSSO
DU5
EAP
EBC
EBD
EBR
EBS
EBU
EHE
EMB
EMK
EMOBN
EPL
EST
ESX
E~A
E~B
F5P
FUNRP
FVPDL
GTTXZ
H13
HF~
HZ~
H~P
IPNFZ
J.P
KYCEM
LJTGL
M4Z
MK0
ML~
NA5
NY~
O9-
P2P
PQEST
PQQKQ
QWB
RIG
RNANH
ROSJB
RTWRZ
S-T
SNACF
SV3
TEJ
TFL
TFT
TFW
TH9
TTHFI
TUS
TWF
UT5
UU3
V1K
ZGOLN
ZL0
~S~
ABJNI
ABPAQ
ABXYU
AHDZW
CGR
CUY
CVF
ECM
EIF
K1G
NPM
TBQAZ
TDBHL
TUROJ
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c394t-1632ab6124d866bc7e4f7218deaac9b91105ff7d0d0050bc9deaffdaf1b950783
ISSN 1054-3406
IngestDate Fri Aug 16 01:23:01 EDT 2024
Fri Sep 13 09:07:15 EDT 2024
Fri Aug 23 02:27:13 EDT 2024
Sat Sep 28 08:19:29 EDT 2024
Tue Jun 13 19:26:21 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Bayesian-augmented control
entropy balancing
power prior
asymmetrical randomization
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c394t-1632ab6124d866bc7e4f7218deaac9b91105ff7d0d0050bc9deaffdaf1b950783
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2428-3298
0000-0003-4736-2597
0000-0003-0954-3397
PMID 35072583
PQID 3087517207
PQPubID 196226
PageCount 17
ParticipantIDs proquest_miscellaneous_2622481447
proquest_journals_3087517207
crossref_primary_10_1080_10543406_2021_2021226
pubmed_primary_35072583
informaworld_taylorfrancis_310_1080_10543406_2021_2021226
PublicationCentury 2000
PublicationDate 2022-Jan-02
PublicationDateYYYYMMDD 2022-01-02
PublicationDate_xml – month: 01
  year: 2022
  text: 2022-Jan-02
  day: 02
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Philadelphia
PublicationTitle Journal of biopharmaceutical statistics
PublicationTitleAlternate J Biopharm Stat
PublicationYear 2022
Publisher Taylor & Francis
Taylor & Francis Ltd
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Ltd
References cit0011
cit0012
cit0010
Bernardo J. M. (cit0001) 1996; 4
cit0008
cit0009
cit0006
cit0007
cit0004
cit0005
cit0002
cit0013
cit0003
cit0014
References_xml – volume: 4
  start-page: 111
  year: 1996
  ident: cit0001
  publication-title: Far East Journal of Mathematical Sciences
  contributor:
    fullname: Bernardo J. M.
– ident: cit0014
  doi: 10.1002/pst.2172
– ident: cit0002
– ident: cit0009
  doi: 10.1111/1468-0262.00442
– ident: cit0003
– ident: cit0013
  doi: 10.1002/pst.1879
– ident: cit0005
– ident: cit0004
– ident: cit0011
  doi: 10.1111/j.1467-985X.2007.00527.x
– ident: cit0010
  doi: 10.1214/ss/1009212673
– ident: cit0012
  doi: 10.1111/rssb.12027
– ident: cit0006
  doi: 10.1080/10543406.2020.1730877
– ident: cit0007
  doi: 10.1038/bcj.2016.84
– ident: cit0008
  doi: 10.1093/pan/mpr025
SSID ssj0015784
Score 2.3270686
Snippet In pediatric or orphan diseases, there are many instances where it is unfeasible to conduct randomized and controlled clinical trials. This is due in part to...
SourceID proquest
crossref
pubmed
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 4
SubjectTerms asymmetrical randomization
Bayesian-augmented control
Child
Entropy
entropy balancing
Humans
power prior
Propensity Score
Randomized Controlled Trials as Topic
Research Design
Sample Size
Title Power priors with entropy balancing weights in data augmentation of partially controlled randomized trials
URI https://www.tandfonline.com/doi/abs/10.1080/10543406.2021.2021226
https://www.ncbi.nlm.nih.gov/pubmed/35072583
https://www.proquest.com/docview/3087517207/abstract/
https://search.proquest.com/docview/2622481447
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9rIXxMatbCAjob10GYnj3B4nbhUSqBKdGLxEduKMoDaJ1uSh-yf8W44vuRQ6YLxEkdM4cc7X4-PP54LQi8C2met7xBJuxC3KXW5FQgiLwVQS-gkLIsV3fPjoT8_p-wvvYjT6MfBaamp-mlxvjSv5H6lCG8hVRsneQrJdp9AA5yBfOIKE4fhPMp7JEmeT6iqXFXMUoyq52rJaT7j0WEwU0aq4T-31ymo2Yc3l0sQbKUuxkv2yxWLdeq0vwASFCSwtl_k1nKqyHqsbbFiel9W3DVJcBijp3M-dPmkU996w4nIh8p6U18zrF2hfNz1E37El07tBbQneIS9BiOIlBlQlGG7UcqltEl0b9QqLVS8w6tXo357f7HCmlSkdzMoqYu53fa8dJOWj5JNguU8cdSBkS37tX-a9zhvRMWlS225i2UNsurmDdkkQebCu3z2bvv76uduiAlWnXBbaYbbhYaH9cuv7bBg-G2lxb17cKCNnfg_dNZLFZxpq-2gkigN0PNMiXp_geR-ttzrBx3jWJz5fH6C9T53w76PvCpxYgxNLcGIDTtyBExtw4rzAEpx4CE5cZrgDJ-7BiXtwYg3OB-j87Zv5q6llCntYiRvR2oI1AGEcbGuahr7Pk0DQLABbMxWMJRGH-df2sixI7VSmJ-JJBBeyLGWZwyNP7js_RDtFWYjHCGc288MgCZyMelQQjyUkcV07JdyBZjsdo9P2q8eVzt8S_1HeYxQNZRPXijjLdJWb2P3LvUetIGOjJuAWWTMClgl2MEbPu8ugxOXOHCtE2axi4oMlHTqUwm8eaQB0b-vCiIkXuk9uO5JDtNf_L4_QTn3ViKdgQdf8mcHyT9Ugw2I
link.rule.ids 315,786,790,27957,27958,60241,61030
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELZaeigXWuhrW6CuVHEiK8fO81hVRdsWVntYJG6Wn2jbJVltskLLr-9MHstDQj1wSaIkjmxn7Pk8nvmGkK8pY0okMQ-cyHUQaaGD3DkXKFAlWWJUmjf2jrNxMjqPfl3EF3diYdCtEtfQviWKaOZqHNxojO5d4uCMAZEMPQx42BwARDwnLxJQODg4BRtvdhJAIpudZSgSYJk-iuexz9zTT_fYSx_HoI0uOnlFTN-K1gXl73BV66G5eUDw-LRmviY7HVSl31rZ2iXPXLFHjiYt1_X6mE5vQ7eqY3pEJ7cs2Os9so0wtmWBfkP-TDAZG10sZ-Wyomj7pWhVLhdrqtG30oACpdeNlbais4Ki3ypVq8urLjKqoKWnC5RyNZ-vaedfP3eWgqq15dXsBi6bBCTVW3J-8mP6fRR0WR4CI_KoDgAQcqUBaEU2SxJtUhd5WJZm1illcg2TMYu9Ty2zyFWjTQ4PvLfKhzqPcRPyHdkqysJ9INQzlWSpSUMfxZHjsTLcCMEs1yHcZnZAhv2_lYuWzEOGHUdq39kS-1l2nT0g-V0JkHVjRfFtyhMp_lN2vxcX2c0LUAQTCABmZOmAfNk8hhGN2zSqcOWqkjwBWJXBQhfeed-K2aa2AlrM40x8fELFPpOXo-nZqTz9Of79iWxzjOdAmxLfJ1v1cuUOAGXV-rAZRv8AG0oaoA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSKgXHuW1UMBIqKdm5dh5HhGwKq_VHlqJm-UnWtgm0SYrtP31zDjJliJVHHpJoiSObGfs-Tye-YaQtzljSmQpj5wodZRooaPSORcpUCVFZlReBnvHt3l2cpZ8_p6O3oTt4FaJa2jfE0WEuRoHd2P96BEHZ4yHZOhgwONwAAxxm9zJMGUWRnGw-W4jAQQybCxDkQjLjEE8133minq6Ql56PQQNqmh2n-ixEb0Hyq_pptNTc_EPv-ONWvmA3BuAKn3XS9ZDcstVB-Ro0TNdb4_p6WXgVntMj-jikgN7e0D2EcT2HNCPyM8FpmKjzXpZr1uKll-KNuW62VKNnpUG1Cf9HWy0LV1WFL1Wqdr8OB_ioipae9qgjKvVaksH7_qVsxQUra3PlxdwGdKPtI_J2ezj6fuTaMjxEBlRJl0EcJArDTArsUWWaZO7xMOitLBOKVNqmIpZ6n1umUWmGm1KeOC9VT7WZYpbkE_IXlVX7hmhnqmsyE0e-yRNHE-V4UYIZrmO4TazEzIdf61seioPGQ8MqWNnS-xnOXT2hJR_C4Dsgg3F9wlPpPhP2cNRWuQwK0ARTB8AiJHlE_Jm9xjGM27SqMrVm1byDEBVActceOdpL2W72gpoMU8L8fwGFXtN7i4-zOTXT_MvL8g-x2AONCjxQ7LXrTfuJUCsTr8Kg-gPpfoZTQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Power+priors+with+entropy+balancing+weights+in+data+augmentation+of+partially+controlled+randomized+trials&rft.jtitle=Journal+of+biopharmaceutical+statistics&rft.au=Yu%2C+Guanglei&rft.au=Bian%2C+Yuanyuan&rft.au=Gamalo%2C+Margaret&rft.date=2022-01-02&rft.issn=1054-3406&rft.eissn=1520-5711&rft.volume=32&rft.issue=1&rft.spage=4&rft.epage=20&rft_id=info:doi/10.1080%2F10543406.2021.2021226&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_10543406_2021_2021226
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1054-3406&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1054-3406&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1054-3406&client=summon